London stocks climb as omicron fears fade

Published: Updated:

UK shares rose on Thursday as markets globally rallied after two research studies showed omicron was less severe compared with the delta coronavirus variant, lifting investor sentiment.

For all the latest headlines follow our Google News channel online or via the app.

The commodity-heavy FTSE 100 gained 0.2 percent, extending its two-day rally, while the domestically focused mid-cap index added 0.6 percent with airline stocks Wizz Air and EasyJet leading gains.

Energy and mining stocks added 0.5 percent and 0.3 percent respectively, tracking a rise in commodity prices on easing concerns about omicron and upbeat U.S. economic data.

Drug maker AstraZeneca inched up 0.3 percent after saying its COVID-19 vaccine was effective against the omicron coronavirus variant following a third dose.

Two separate studies in South Africa and London on Wednesday suggested the risk of hospitalization from the omicron variant was much less compared with the Delta variant.

Read more:

AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study

Top Content Trending